Home
Product Name | ent-kaurane-3,16,17-triol |
Price: | Inquiry |
Catalog No.: | CN08927 |
CAS No.: | 130855-22-0 |
Molecular Formula: | C20H34O3 |
Molecular Weight: | 322.5 g/mol |
Purity: | >=98% |
Type of Compound: | Diterpenoids |
Physical Desc.: | Powder |
Source: | The herbs of Croton laevigatus |
Solvent: | Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc. |
SMILES: |
Contact us | |
---|---|
First Name: | |
Last Name: | |
E-mail: | |
Question: | |
Description | ent-Kaurane-3α,16β,17-triol (Compound 3) is an anticancer agent. ent-Kaurane-3α,16β,17-triol induces apoptosis in HCT116 cells[1]. |
In Vitro | ent-Kaurane-3α,16β,17-triol (Compound 3; 0-100 μM; 24 h) 抑制 HepG2 和 HCT116 细胞增殖,IC50 值分别为 45.5 和 29.84 µM[1]。 ent-Kaurane-3α,16β,17-triol (20 and 30 μM; 24 h) 抑制 HCT116 细胞集落形成[1]。 ent-Kaurane-3α,16β,17-triol (30 and 40 µM; 48 h) 诱导人结肠癌细胞周期阻滞[1]。 ent-Kaurane-3α,16β,17-triol (30 and 40 µM; 72 h) 诱导人结肠癌细胞凋亡[1]。 Cell Viability Assay[1] Cell Line: HepG2, MDA-MB-231, SCG-7901, OVCAR3 and HCT116 cells Concentration: 0-100 μM Incubation Time: 24 h Result: Showed inhibitory effects with IC50s of 29.84, 45.5, >100, >100 and >100 μM against HCT116, HepG2, MDA-MB-231, SCG-7901 and OVCAR3 cells, respectively. Cell Cycle Analysis[1] Cell Line: HCT116 Concentration: 30 and 40 µM Incubation Time: 48 h Result: Significantly increased the cell population at the G0/G1 phase in a dosedependent manner. Apoptosis Analysis[1] Cell Line: HCT116 Concentration: 30 and 40 µM Incubation Time: 72 h Result: Increased the percentage of both early and late apoptotic cells. Western Blot Analysis[1] Cell Line: HCT116 Concentration: 30 μM Incubation Time: 72 h Result: Increased the expression levels of cleaved PARP, p27 and p53, and decreased the expression levels of cyclin D1 and CDK2. |
Density | 1.2±0.1 g/cm3 |
Boiling Point | 461.6±40.0 °C at 760 mmHg |
Flash Point | 207.1±21.9 °C |
Exact Mass | 322.250793 |
PSA | 60.69000 |
LogP | 3.34 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |